Clinical Study Results
Where can I learn more about the study?
You can find more information about this study on the website listed below. If a full
report of the study results is available, it also can be found there.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03075267” into the
search box and click “Search”.
The full title of your study is: A Phase I, Randomized, Double-Blind, Parallel-Group
Study to Assess the Pharmacokinetics and Safety of Two Doses of PT010 and a Single
Dose of PT003 in Healthy Chinese Adult Subjects Following a Single Administration
and After Chronic Administration for 7 Days
The protocol number of your study is: PT010010 (D5980C00005)
Pearl Therapeutics, Inc., a member of the AstraZeneca Group, sponsored this study
and has its headquarters at 280 Headquarters Plaza, Morristown, NJ 07960.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical
Research Participation (CISCRP) is a non-profit
organization focused on educating and informing the
public about clinical research participation. CISCRP is
not involved in recruiting patients for clinical studies, nor
is it involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 510
Boston, MA 02109
1-877-MED-HERO
www.ciscrp.org
6
Version: V2.1 11/2018